Literature DB >> 1674791

ANCA and infection.

W H Schmitt, E Csernok, W L Gross.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1674791     DOI： 10.1016/0140-6736(91)93102-f

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

Review 1.  Clinical immunology.

Authors:  R J Powell
Journal:  Postgrad Med J       Date:  1991-11       Impact factor: 2.401

2.  Detection of anti-neutrophil cytoplasmic antibodies after acute Plasmodium falciparum malaria.

Authors:  C Wenisch; H Wenisch; H C Bankl; M Exner; W Graninger; S Looareesuwan; H Rumpold
Journal:  Clin Diagn Lab Immunol       Date:  1996-01

3.  Multireactive pattern of serum autoantibodies in asymptomatic individuals with immunoglobulin A deficiency.

Authors:  N Barka; G Q Shen; Y Shoenfeld; I J Alosachie; M E Gershwin; H Reyes; J B Peter
Journal:  Clin Diagn Lab Immunol       Date:  1995-07

4.  Autoantibodies in malaria, tuberculosis and hepatitis B in a west African population.

Authors:  A O Adebajo; P Charles; R N Maini; B L Hazleman
Journal:  Clin Exp Immunol       Date:  1993-04       Impact factor: 4.330

5.  Immunization with anti-neutrophil cytoplasmic antibody (ANCA) induces the production of mouse ANCA and perivascular lymphocyte infiltration.

Authors:  M Blank; Y Tomer; M Stein; J Kopolovic; A Wiik; P L Meroni; G Conforti; Y Shoenfeld
Journal:  Clin Exp Immunol       Date:  1995-10       Impact factor: 4.330

6.  An audit of ANCA in routine clinical practice.

Authors:  J D Edgar; S A McMillan; I N Bruce; S K Conlan
Journal:  Postgrad Med J       Date:  1995-10       Impact factor: 2.401

Review 7.  ANCA and associated diseases: immunodiagnostic and pathogenetic aspects.

Authors:  W L Gross; W H Schmitt; E Csernok
Journal:  Clin Exp Immunol       Date:  1993-01       Impact factor: 4.330

8.  Wegener's granulomatosis overlapped with Takayasu arteritis.

Authors:  S Yamasaki; K Eguchi; Y Kawabe; T Tsukada; S Nagataki
Journal:  Clin Rheumatol       Date:  1996-05       Impact factor: 2.980
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.